Dear Postgraduate Student,
I hope this message finds you well.
I would like to invite you to attend online the Avicenna Alliance - Association for Predictive Medicine open to all, global lecture on in silico medicine and in silico oncology, including the "birth" of the latter, that I will deliver (online) on 26 August 2026, 17:00 - 18:00 CEST = 18:00 - 19:00 EEST. The lecture is offered in collaboration with the Virtual Physiological Human Institute.
The title of my lecture is:
"In silico medicine and digital twins through the foundational paradigm of in silico oncology: historical landmarks and current evolutionary status"
The event has been scheduled, following an invitation I received from the President and Secretary General of the Avicenna Alliance – Association for Predictive Medicine, Thierry Marchal.
For more information on the event and free registration, please visit:
LECTURE WEBSITE INCLUDING FREE OPEN TO ALL REGISTRATION FORM
You may also find at the end of this message a brief introduction into the new scientific, technological and gradually medical-clinical discipline of in silico medicine.
The nearly final presentation slides for my lecture are accessible (in pdf format -no videos can play though it) via the link:
PPT IN PDF FORMAT OF G STAMATAKOS FOR HIS AVICENNA LECTURE ON IN SILICO MEDICINE
The above slides include, inter alia, representative documentation of my global, unequivocal, undisputed and definitive recognition as the "father of in silico medicine". I am glad to communicate this development to you.
Feel free to further disseminate this announcement to anyone you might wish.
With my best wishes
Georgios Stamatakos
Member of the Editorial Board of Scientific Reports, Nature Portfolio
Research Professor Georgios S. Stamatakos
Father of In Silico Medicine https://tinyurl.com/FatherISM
Institute of Communication and Computer Systems (ICCS)
School of Electrical and Computer Engineering (ECE)
National Technical University of Athens (NTUA)
Director and Founder, In Silico Oncology and In Silico Medicine Group, ICCS, ECE, NTUA
Co-Chair, Cancer and In Silico Oncology Task Force, Avicenna Alliance - Association for Predictive Medicine
Visiting Professor, Medical School, University of Saarland, Germany (1/7–15/9/2019)
Visiting Professor, ECE, NTUA (2016-2019)
Iroon Polytechniou 9, GR 157 80 Zografos, Greece
E-Mail: gestam@central.ntua.gr , Tel. +30 210 7722287, www.in-silico-oncology.iccs.ntua.gr
NEXT OPEN GLOBAL WEBINAR OF GSS: https://tinyurl.com/InSilicoMedicineAug2025GSS
*** A BRIEF INTRODUCTION TO IN SILICO MEDICINE ***
In silico medicine is a new scientific, technological, and gradually medical-clinical discipline that aims to support patient-specific disease prevention, diagnosis, prognosis and optimization of clinical interventions, as well as to mimic clinical studies and trials through the conduct of in silico experiments, i.e., experiments on a computer.
Such experiments make use of models or digital twins of parts of - or the entirety of - the human body, and eventually its environment, as well as these models’ natural behavior and/or interactions with candidate intervention(s). The models utilized can be based on mechanistic multiscale modeling and simulation and/or artificial intelligence (AI) modelling. All models must be strictly clinically validated and certified before being used in an actual clinical setting.
Since the "birth" of in silico medicine - also known as computational medicine - at the National Technical University of Athens in 2002 under my lead, there have been certain key historical milestones in its emergence, early development, and evolution, which, along with representative discipline achievement examples, will be outlined during the lecture.